ORIGINAL ARTICLE |
|
Year : 2020 | Volume
: 63
| Issue : 5 | Page : 81-86 |
|
Uterine tumor resembling ovarian sex cord tumor: A series of six cases displaying varied histopathological patterns and clinical profiles
Kavneet Kaur1, Madhu Rajeshwari1, Niteeka Gurung1, Hemanth Kumar1, Mehar C Sharma1, Rajni Yadav1, Sunesh Kumar2, Smita Manchanda3, Seema Singhal2, Sandeep R Mathur1
1 Department of Pathology, All India Institute of Medical Sciences, New Delhi, India 2 Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India 3 Department of Radiology, All India Institute of Medical Sciences, New Delhi, India
Correspondence Address:
Sandeep R Mathur Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi - 110 029 India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/IJPM.IJPM_340_19
|
|
Introduction: Uterine tumors resembling ovarian sex cord tumor (UTROSCT) are a unique group of neoplasms with diverse morphology and immunophenotypic characteristics, coexpressing sex cord, epithelial, and smooth-muscle markers. To date, less than 100 cases have been reported and there is paucity of data concerning their clinical behavior. Materials and Methods: All cases of uterine body tumors diagnosed over a period of two and a half years (2016-2018) were retrieved. Histopathological features were reviewed and extended panel of immunohistochemistry was performed to identify cases of UTROSCTs. Results: Six cases of UTROSCTs were identified with a median age of 46.5 years. Four of them presented with menorrhagia, while two with postmenopausal bleeding including one with a history of carcinoma breast. Three of these cases were initially misdiagnosed as endometrial stromal sarcoma and adenocarcinomas. They all underwent hysterectomy with bilateral salpingo-oophorectomy. Conclusion: It is considered a tumor with low malignant potential; however, one out of six cases (16.7%) in our study showed metastasis, within 1 year of diagnosis. It is important to recognize this entity as it mimics a wide range of both benign and malignant tumors. Molecular pathogenesis and exact management protocols remain elusive due to rarity,hence, multi-institutional studies are warranted.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|